vimarsana.com

Page 5 - உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் பட்டியல் ஆஃப் அவசியம் மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Latest Articles

Latest Articles
freerepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freerepublic.com Daily Mail and Mail on Sunday newspapers.

Latest Articles

Latest Articles
freerepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freerepublic.com Daily Mail and Mail on Sunday newspapers.

Russia developing coronavirus antidote with a reported 99% efficacy rate

https://www.afinalwarning.com/486478.html (Natural News) Russia has announced that it has developed an “antidote” against Wuhan coronavirus (COVID-19) infections. The country’s medical regulator touted the new drug’s efficacy rate of “more than 99 percent” based on previous studies. If clinical trials are successful, Russia’s new drug will be the first etiotropic COVID-19 medication – a treatment that directly targets the cause of a disease. The Russian Federal Medical-Biological Agency (FMBA) said Dec. 30 that its potential anti-COVID drug would become the world’s first direct-acting antiviral antidote. FMBA Head Veronika Skvortsova remarked: “This is the first etiotropic drug that directly affects the virus. In fact, this is an antidote for coronavirus infection.”

Ivermectin Highlighted at Senate Hearing for Early Prevention and Treatment of COVID-19

Ivermectin Highlighted for Early Prevention and Treatment of COVID-19 Doctors at a recent Senate hearing stressed the importance of more research and guidance on the early or preventative treatment of COVID-19 in the fight against the CCP virus, even after the roll-out of vaccines. The Senate Homeland Security and Governmental Affairs Committee, led by Sen. Ron Johnson (R-Wis.), held a second hearing on early outpatient treatment for COVID-19 on Dec. 8 to “discuss early treatment options that attack the disease in the first stage by limiting viral replication” in hopes of preventing disease progression, hospitalizations, and deaths. Dr. Armand Balboni, CEO of Appili Therapeutics Inc., said there’s a need for options to combat the virus at various stages, particularly “at the moment of exposure or confirmed infection.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.